Why Asthma Research Matters Right Now
Asthma affects roughly 25 million people across the United States, yet no single treatment works for everyone. The medications sitting on pharmacy shelves today exist because someone before you raised their hand and said, "I'll try this." Clinical trials bridge the gap between laboratory discoveries and the inhalers, biologics, and pills that eventually become standard care.
The landscape of asthma research has shifted considerably in recent years. Where trials once focused broadly on anyone with wheezing and shortness of breath, researchers now design studies around specific subtypes — eosinophilic asthma, allergic asthma, exercise-induced asthma, and obesity-related asthma, to name a few. This means participants in asthma clinical trials for adults and children alike are more likely to receive treatments matched to their particular form of the condition.
At major research hubs like the American Lung Association's Airways Clinical Research Centers — with locations spanning from the University of Arizona in Tucson to Duke University in North Carolina and the Vermont Lung Center — recruitment is ongoing for studies that examine everything from repurposed medications to next-generation biologics. One example is the TRIM trial, which is investigating whether roflumilast, a drug previously used for COPD, can help adults with poorly controlled asthma and elevated BMI. These are the kinds of questions that only well-designed studies can answer.
Understanding the Different Phases
Not all clinical trials are created equal, and knowing which phase a study is in helps set realistic expectations.
Phase 1 trials represent the earliest stage of human testing. They typically involve a small group — often healthy volunteers, though sometimes people with mild asthma — and focus primarily on safety and dosing. The question here is not "does this work wonders?" but rather "is this safe enough to keep studying?"
Phase 2 trials expand the circle. Researchers enroll participants who actually have the condition and begin measuring effectiveness alongside safety. These studies might involve a few hundred people and can last several months to a year. If you join a Phase 2 asthma trial, you're helping researchers figure out whether the investigational treatment improves lung function, reduces exacerbations, or eases day-to-day symptoms.
Phase 3 trials are the large-scale efforts that often make headlines. These can enroll hundreds or even thousands of participants across multiple states and countries. The SOLAIRIA studies, for instance, are Phase 3 trials currently evaluating an investigational biologic called GB-0895 in adults and adolescents with severe uncontrolled asthma. Participants receive either the study drug or placebo and are monitored for a full year. Phase 3 is where the evidence builds toward potential regulatory review.
Phase 4 trials take place after a treatment is already available to the public. They monitor long-term safety and real-world effectiveness, sometimes comparing the newer option against older standards of care.
What Participation Actually Looks Like
If you're searching for asthma clinical trials near me, you should know what the day-to-day commitment involves. Most trials begin with a screening visit where the research team confirms your diagnosis, reviews your medical history, and runs baseline tests like spirometry, blood work, and sometimes allergy skin testing. This screening determines whether you meet the eligibility criteria — factors like age, current medications, asthma severity, and the absence of other lung conditions.
Once enrolled, you'll typically attend regular study visits. Some trials require monthly check-ins; others may ask you to come in every few weeks. Between visits, you might keep a daily asthma diary, use a peak flow meter at home, or respond to periodic phone check-ins. The TRIM trial, for example, involves four clinic visits with breathing tests, questionnaires, and blood draws, plus daily diary cards.
Here's a snapshot of what different types of asthma trials tend to involve:
| Trial Type | Typical Duration | Visit Frequency | Common Procedures | Potential Compensation Range |
|---|
| Phase 1 (safety/dosing) | Weeks to 3 months | Weekly or biweekly | Blood draws, vital signs, spirometry | $500–$1,500 |
| Phase 2 (efficacy signals) | 3–12 months | Monthly | Lung function tests, symptom diaries, questionnaires | $800–$2,000 |
| Phase 3 (pivotal studies) | 6–24 months | Monthly to quarterly | Comprehensive assessments, possibly bronchoscopy | $1,000–$3,900 |
| Observational/registry | 1–5 years | Quarterly or biannually | Surveys, spirometry, no experimental drug | $100–$500 |
Compensation varies widely. The Brigham and Women's Hospital Asthma Research Center, for example, has offered up to $3,900 for participants completing 26 visits over nearly two years. Clinical Research of West Florida has advertised compensation up to $1,100 for asthma trials, while the University of Wisconsin has offered amounts around $1,350. These payments are meant to offset your time and travel — they are not wages, and the amount generally reflects the burden of participation rather than the risk involved.
The Real Benefits and the Honest Risks
Maria, a 42-year-old teacher from Chicago, spent years cycling through inhaler combinations that left her winded after climbing a single flight of stairs. When her pulmonologist mentioned a Phase 3 trial for severe eosinophilic asthma, she hesitated. "I was nervous about being a guinea pig," she recalls. But after six months in the study, her exacerbations dropped from four per year to none. She also received more attentive monitoring than she had ever experienced in routine care — regular lung function tracking, direct phone access to a study coordinator, and detailed explanations of every test result.
Stories like Maria's are not unusual. Participants in severe asthma clinical trials often report that the heightened medical attention alone feels like a benefit, regardless of whether the experimental drug works for them. You walk away knowing your lung function numbers, your triggers, and your patterns in a way that standard clinic visits rarely provide.
But there are real trade-offs. The drug being studied might not work for you — and in a randomized, double-blind, placebo-controlled trial, you might not receive the active treatment at all. Side effects can be unpredictable. Some trials require washout periods where you temporarily stop your regular medications, which can be uncomfortable or even risky if not carefully managed. The time commitment is genuine: missed workdays, travel to study sites, and the mental energy of tracking symptoms daily.
Eligibility is another hurdle. Many asthma clinical trials have narrow inclusion criteria. You might need to be on a stable medium-to-high-dose inhaled corticosteroid for at least a year, have a documented history of exacerbations, and fall within a specific age range. The SOLAIRIA trials, for instance, require participants to be between 12 and 80 years old with a physician-diagnosed asthma history of at least two years and a weight above 40 kg. If you don't fit the profile, the research team simply cannot enroll you.
How to Find a Trial That Fits
The most comprehensive starting point is ClinicalTrials.gov, a database maintained by the National Institutes of Health. You can search by condition ("asthma"), location (your city or state), and status ("recruiting"). The advanced search function lets you filter by age group, study phase, and even by the type of intervention — inhaled, oral, injectable, or behavioral.
The American Lung Association also maintains a listing of trials at its Airways Clinical Research Centers across the country. These sites are located in Arizona, Illinois, New York, North Carolina, and Vermont, with additional affiliate locations. Private research organizations like the Florida Center for Allergy & Asthma Research and Stay Medical in Miami offer asthma research studies compensation along with access to investigational treatments.
Your own pulmonologist or allergist can be a valuable bridge. Many physicians have relationships with nearby academic medical centers and can tell you whether a particular trial is reputable and appropriate for your situation. Some practices even have research coordinators on staff who can screen you for open studies during a regular appointment.
When you find a trial that seems promising, call the study coordinator and ask pointed questions: What is the purpose of this study? How many visits are required? What happens if I experience side effects? Will I receive the results of any tests performed during the trial? The research team should answer every question clearly and without pressure. You have the right to withdraw at any time, for any reason.
What the Informed Consent Document Really Means
Before you join any trial, you will be asked to sign an informed consent form. This is not a waiver of your rights. It is a document that explains the study's purpose, procedures, potential risks, and alternatives in plain language. Read it thoroughly. Bring a family member or friend to your screening visit to serve as a second set of ears. If something in the consent form feels unclear or troubling, speak up. The process is designed to protect you, and a legitimate research team will welcome your questions rather than rush past them.
The consent form should also spell out who covers the costs. In most asthma trials, the study sponsor pays for the investigational drug, all study-related procedures, and any extra tests beyond routine care. Routine costs — like your regular inhaler refills — typically remain your responsibility or your insurance's. Transportation to and from the study site is generally not reimbursed directly, though many trials offer a stipend to help offset travel expenses.
Investigators are required to report serious adverse events and to stop a study if safety signals emerge. The oversight infrastructure — institutional review boards, data safety monitoring committees, and federal regulations — exists to catch problems before they spiral. That said, the system is not perfect, and your own vigilance matters. Pay attention to how your body responds, and report anything unusual to the study team immediately.
A Practical Path Forward
If you've been struggling with asthma that doesn't respond well to standard treatments, learning about clinical trials is a reasonable next step. Start by writing down your current medications, your exacerbation history over the past year, and any questions you want answered. Then visit ClinicalTrials.gov or the American Lung Association's trial finder to see what's recruiting near you.
Talk to your doctor. Pick up the phone and call a study coordinator. You are not committing to anything by making that first call — you are gathering information. Some people discover that they don't qualify for the trial they had in mind but are referred to a different study that fits them better. Others decide that the time commitment is too much for their current season of life. Either outcome is perfectly fine.
The medications that have transformed asthma care over the past two decades — biologics like tezepelumab, mepolizumab, and benralizumab — reached patients because thousands of volunteers stepped forward and said yes to the unknown. That legacy continues with every new trial that opens its doors. Whether you walk through one of those doors is a personal decision, but knowing what's on the other side will help you make it with clarity.
研究の知恵